IBC Members Page
Resources:
Reviewer Form v1 (Open format word document)
  Reviewer Form v2 (Fillable Field Document)
  Miami Review Policy and Exemptions
  NIH Guidelines Overview
  IBC Appointment Letter

New applications (5 Day All-Committee comments period)
These applications should be considered by all members. If after 5 days no member has requested a convened committee review, one or more members will be designated to be part of the review subcommittee.
Application
Number
PI
Date
Posted
 

Type:
rDNA or BioHazard

Title

Type of review required*

         

* Committee members can call for a convened meeting to discuss any application regardless of NIH or local policy requirements, see Miami Review Policy ands Exemption link above.

Applications under review (post-5 day comment period)
Application
Number
PI
Date
Posted
 

Type:
rDNA or BioHazard

Title

Type of review required*

 

 

         

 

 

 
Approved Protocols
Protocol
Number
PI Date
Approved
Type:
rDNA or BioHazard
Title
001  Kennedy 30-Apr-2016
rDNA

Methods development for human Pancreatic Cancer cell-line metabonomics studies:
Growth media comparison and drying comparison

002 Kennedy 30-Apr-2016
rDNA

Engineering Oncolytic Adenoviruses for Pancreatic Cancer Therapy

003 Kennedy 30-Apr-2016
rDNA

Characterizing Biomarkers of Pancreatic Cancer in an Orthotopic Mouse Model

004 Zhu 30-Apr-2016
BioH

Mass spectrometry based metabolomics for the study of bacterial metabolites and their
impact to human colorectal health

005 Ferguson 30-Apr-2016
BioH

Alternative routes of gut microbial methylamine metabolism that may limit trimethylamine
N-oxide, a trigger for atherosclerosis (RG1).

007 Robinson 7-Apr-16

rDNA

Adenovirus use in tissue explants and cultured cells

008 Kennedy 22-Sep-16

rDNA

Assessment of Toxicity and Systemic Distribution of an Engineered Adenovirus
Containing a HMGA1 Hyperbinding Site in C57BL/6 Mouse Model (PDF)

010

Wilson

17-Apr-17

rDNA

Use of 3rd generation lentiviral vectors for in vitro gene transfer (PDF)

011 Rao 5-Jul-17

Tech

FORESIGHT: Predicting & Preventing Emergent Epidemics in Humans & Livestock

012 Wilson 20-Dec-2017
Bio-Hazard
(non-human)

Regulation of Immune Responses to MCMV by SLAMF9

013

Actis
16-May-2019
BioHazard

Study of Acinetobacter baumannii virulence

014 Balish 5-Nov-2019
BioHazard BL2

Culture of Mycoplasmas from Human Urine Samples and Urethral Swabs

015 Schumacher 31-Oct-2019
rDNA - BL1

Endocardial development in zebrafish

 

Complete NIH Guidlines (PDF)